Chronic Obstructive Pulmonary Disease Clinical Trial
Official title:
Effects of Respiratory Muscle Training and Respiratory Exercise in Exercise Tolerance, Performing Daily Life Activities and Quality of Life of Patients With COPD.
In patients with chronic obstructive pulmonary disease (COPD) breaths at an abnormally high lung volume causes the inspiratory muscle to operate at non-optimal lengths, which reduce their maximal contractile forces. In addition, causes non thoraco abdominal synchronize, reduced inspiratory muscle strength and is associated with dyspnea and decreased exercise capacity. For these patients inspiratory muscle training (IMT) is a widely employed form of rehabilitation also targeting the respiratory muscle. In addition, patients often experience shortness of breath and a decline in exercise tolerance, resulting in disability in the performance of activities of daily living (ADL). The aims of this trial are to evaluate the effects of inspiratory muscle training associated with aerobic training on strength and endurance of inspiratory muscle, thoracic abdominal synchrony, exercise tolerance and quality of life patients with COPD. To compare the responses with the effects of aerobic training plus exercises of the trunk and upper limbs, and stretching of large muscle groups of the trunk. To compare difference in the perception of dyspnea during the ADL set (Borg Scale) with perception of dyspnea self-reported in the Medical Research Council (MRC), the London Chest Activity of Daily Living (LCADL) and the Pulmonary Functional Status and Dyspnea Questionnaire - Modified version (PFSDQ-M) before start the protocol. To investigate changes on perception of dyspnea (Borg scale), metabolic and ventilatory responses during a standard set of ADL tasks after a physical training and to evaluate and compare changes on perception of dyspnea. The hypothesis are that the ventilatory efficiency during the performance of ADL and the dyspnea reported from borg scale, the LCADL and the PFSDQ-M that quantifies the functional performance (change in activity levels) are improved during the IMT in conjunction with general exercise training in patients with COPD. The MIT increases the strength and endurance of inspiratory muscle, the exercise capacity and the quality of life compared to the general physical training. However, compared to the thorax abdominal synchronizes, higher modification is verified in the general physical training group with specific exercise to torso, limbs and stretching of the higher muscle group.
Methodology Sample Is a prospective longitudinal. Forty patients with COPD to moderate to
very severe obstruction (ratio [FEV1/FVC] <70%) and FEV1 <80% predicted (RABE et al., 2008),
age ranging from 50 to 80 years old, both sexes will be assessed and treated. All subjects
carry out spirometry before and after bronchodilator (BD) under medical supervision.
Experimental Procedure Patients with COPD will undergo a physical assessment of general and
specific respiratory system and receive guidance on the tests and treatments proposed in
this study. All of them will be instructed to maintain the medication prescribed.
The evaluation will include the following tests: medical history, St George's Respiratory
Questionnaire, Medical Research Council (MRC), assessing the strength and endurance of
respiratory muscle, spirometry, maximal exercise testing endurance test of the lower limbs,
the Six Minute Walk Test and plethysmography of inductance.
Assessment of respiratory muscle strength The assessment of respiratory muscle strength will
consist of measures of maximal inspiratory pressure (MIP) and maximal expiratory pressure
(MEP), performed according to Black and Hyatt (1969). The measures will be carried out using
a manometer scaled in cmH2O (Ger-Ar) fitted with an adapter nozzle, which contains a hole
two millimeters in diameter to eliminate the pressures of facial muscles. The subjects carry
out the measures in standing posture using a nose clip. The MIP will be measured by a
maximal inspiration, preceded by a maximal expiration starting from residual volume, and MEP
will be measured by a maximal expiration, preceded by a maximal inspiration based on the
total lung capacity. The inspiratory and expiratory must be maintained for at least one
second. Will be performed at least three and maximum five measures will be considered
acceptable if there is a difference of 10% or less between them. The highest value will be
used for statistical analysis. The patients will be allowed a one-minute rest between
measurements.
Assessment of respiratory muscle endurance Incremental and constant tests After measurements
of MIP the endurance of the inspiratory muscles using the PowerBreathe® will be evaluate.
The test starts with incremental 10cmH2O (which is the minimum load of the unit) and every
two minutes there will be an increase 10cmH2O, and conducted a further minute before
increasing the load. The biggest load you can sustain for at least one minute is the maximum
that will be considered. The test will be held constant at 80% of the pressure in the
incremental test, to determine the time limit for implementation, considering 30 minutes as
the maximum time (FIZ et al., 1998; RAMIREZ-SARMIENTO et al., 2002).
In both tests the breathing pattern will be free and the breathing frequency will be noted.
Besides the pressure generated will be monitored by a manometer attached to PowerBreathe® .
Six Minute Walk Test (6MWT) 6MWT will be performed on a track 30 meters long and 1.5 wide,
with markings every 2 feet. Tests will be conducted in accordance with the standards of the
ATS (2002). Every two minutes will be checked the oxygen saturation (SpO2), heart rate (HR),
the sensation of dyspnea and fatigue of the lower limbs by Borg CR10 scale. These measures
associated with the measurement of blood pressure (BP) will be checked before, immediately
after the test and after six minutes. It will be two tests on the same day, at intervals of
30 minutes, to avoid the effect of learning on test performance. It will be considered the
greatest distance for statistical analysis.
Maximum Exercise Testing To perform this test will be followed by the Standardization of
techniques and equipment for exams exercise testing and spirometry (2003), and will be
conducted in a room properly heated, keeping the temperature around 18 ° C and 22 ° C and
relative humidity air between 50% and 70%.
It will be performed by a cardiologist on a treadmill using modified Bruce protocol, which
is a good option for those patients with low functional capacity, such as the elderly and
people with respiratory and cardiovascular disease. This is a protocol in which both the
speed and the incline of the treadmill are increased every three minutes and modified. The
two earlier stages have lower velocities and inclination (SAMORA e VERSIANI, 2008; NEDER e
NERY, 2003).
In addition, to monitoring the continuous ECG tracing at rest and at each stage are checked
the values of SpO2, dyspnea and fatigue of the lower limbs by Borg CR10 scale and BP.
The criteria for interrupting the test are: elevated blood pressure (DBP) to 120 mmHg,
sustained drop in systolic blood pressure (SBP), marked elevation of SBP 260mmHg up,
reaching the maximum HR (HRmax) provided by age, fall in SpO2 below 80%, ECG abnormalities,
the patient's request due to physical exhaustion, dyspnea disproportionate to the exercise
intensity, pain in lower limbs, dizziness or chest discomfort; failure of monitoring systems
and / or record.
Test of endurance of the lower limbs This test will be conducted on a treadmill for up to 30
minutes at an intensity of 80% of the speed and slope obtained at maximal exercise testing.
Inductance plethysmography For this test it will use a system of respiratory inductive
plethysmography (LifeShirt; Vivo Metrics; Ventura, CA), whose sensors are two electrical
conductors sewn to a sleeveless vest, and stay in the region of the nipples and the
umbilical region. There are three electrodes placed in predetermined areas and connected for
a portable, battery, which records the SpO2, electrocardiogram (ECG) and body movements in
three axes (CLARENBACH et al., 2005).
This is a highly reliable instrument used to monitor the volume and time components of
breathing pattern and thoracoabdominal configuration. It is based on changes in
cross-sectional area that occur in the compartments of the chest and abdomen. The method is
minimally invasive, requires no mouthpiece or nose clip (except for calibration), and there
is therefore need for direct contact with air. The accuracy of plethysmography to provide
tidal volume values is satisfactory and depends on an initial calibration and proper
maintenance of the same body position. The equipment will be calibrated in advance the
measures according to the instructions of the device in all subjects. In this study, the
following variables will be analyzed by plethysmography, tidal volume (Vt), respiratory rate
(RR), minute ventilation (VE), the ratio between time to reach peak inspiratory flow and
inspiratory time (PIFT / Ti), flow mean inspiratory (Vt/Ti), percent rib cage contribution
to tidal volume (%RC/Vt) and phase angle (PhAng) (CLARENBACH et al., 2005; PARREIRA et al,
2005).
These measures will be carried out at 90 degrees sitting and standing, resting and doing
exercises with their arms, and walking, to see whether dyssynchrony occurs. The signal
acquisition will total duration of 30 minutes.
Perception of dyspnea assessed by different scales and questionnaires. It will perform a set
of ADL tasks (making bed, taking shower, putting on clothes, brushing teeth and combing
hair, lifting containers on a shelf at eye level and lifting and lowering containers on a
shelf above the scapular waist) patients will evaluate by Borg scale for dyspnea and a
portable system will be used to assess ventilator parameters, oxygen consumption, carbon
dioxide production and heart rate during standardized: wake up and making bed, taking shower
and washing one's back, putting on clothes, brushing teeth and combing hair, lifting and
lowering containers on a shelf at eye level, lifting and lowering containers on a shelf
above the scapular waist and hanging. No specific amount of time is stipulated; the patient
is only instructed to complete the task. During the set of ADL a metabolic system
(MedGraphics VO2000 St. Paul MN, USA) is used. In addition, these patients will self-report
the MRC, LCADL scale and PFSDQ-M, before the start of the protocol to investigate the
difference and the correlation between these instruments.
Training Program After testing and pre-experimental tests, subjects will be randomly divided
into two groups. The treatment program will consist of sessions with duration of about 1
hour or 1 hour and 30 minutes depending on the training, three times per week on alternate
days for 16 consecutive weeks, totaling 48 sessions.
Before the beginning and end of the sessions will be verified measures of blood pressure
(BP), SpO2, HR. Measures of HR, SpO2 and BP will be obtained during the session for
monitoring.
All patients will undergo a general physical training. In this training will be conducted
stretches of upper and lower limbs, treadmill exercise with HR between 70-80% HR max
obtained at maximum exercise test, which could be carried out continuously or with
intervals, up to a maximum of 30 minutes, and resistance exercises to LL, using free
weights, with progressive increases of ½ kg each month to reach 2 kg in the last month.
A group will be associated with inspiratory muscle training (GTMI). The inspiratory muscle
strength training will be done in the POWERbreathe ®, and the patient will breathe for two
minutes, seven times with one minute rest between them, with 15% MIP, the first week, then,
increased 5-10% to reach 60% of the initial MIP after four weeks. After the first month,
every fifteen days the charge will be adjusted to 60% of the new value of MIP. The breathing
pattern will remain free, but the patient will be instructed to release all the air, not to
hyperventilate (HILL et al, 2007).
In other group of patients will be associated a specific exercise program for mobility and
biomechanics of the rib cage, called respiratory exercise group (GCR), as exercises of the
trunk and upper limbs, and stretching of large muscle groups of the trunk.
Upon completion of the protocol will all be assessed.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05102305 -
A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
|
||
Completed |
NCT01867762 -
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03089515 -
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust
|
N/A | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT05552833 -
Pulmonary Adaptive Responses to HIIT in COPD
|
N/A | |
Recruiting |
NCT05835492 -
A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
|
||
Recruiting |
NCT05631132 -
May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?
|
N/A | |
Completed |
NCT03244137 -
Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
|
||
Not yet recruiting |
NCT03282526 -
Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT02546700 -
A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
Withdrawn |
NCT04446637 -
Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD
|
Phase 3 | |
Completed |
NCT04535986 -
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT03295474 -
Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
|
||
Completed |
NCT03256695 -
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Withdrawn |
NCT04042168 -
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT03414541 -
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Completed |
NCT02552160 -
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
|